| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Fatostatin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01299
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Fatostatin inhibits the expression of DME MVD |
[1] |
| Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde inhibits the expression of DME MVD |
[2] |
| Okadaic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01409
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Okadaic acid inhibits the expression of DME MVD |
[3] |
| Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dinophysistoxin 1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00813
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Biotoxin |
| DME Modulation |
Dinophysistoxin 1 inhibits the expression of DME MVD |
[4] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene inhibits the expression of DME MVD |
[5], [6] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME MVD |
[2] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME MVD |
[7] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Jinfukang |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Traditional Medicine |
| DME Modulation |
Jinfukang up-regulates the expression of DME MVD |
[8] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 12 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen up-regulates the expression of DME MVD |
[9] |
| Avobenzone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00411
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Avobenzone up-regulates the expression of DME MVD |
[10] |
| Carmustine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00012
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Carmustine inhibits the expression of DME MVD |
[11] |
| Celecoxib |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00013
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Celecoxib inhibits the drug-metabolizing activity of DME MVD |
[12] |
| Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin inhibits the expression of DME MVD |
[13], [8] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME MVD |
[14] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME MVD |
[15], [5] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME MVD |
[16] |
| Isotretinoin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00186
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Isotretinoin inhibits the expression of DME MVD |
[17] |
| Obeticholic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00165
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Obeticholic acid inhibits the drug-metabolizing activity of DME MVD |
[18] |
| Zoledronic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00140
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Zoledronic acid up-regulates the expression of DME MVD |
[19] |
| Arbutin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00461
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Arbutin inhibits the expression of DME MVD |
[20] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Curcumin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00683
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Curcumin inhibits the expression of DME MVD |
[21] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Genistein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein inhibits the expression of DME MVD |
[22] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| SGA-360 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00720
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
SGA-360 inhibits the expression of DME MVD |
[23] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Archazolid B |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01205
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Archazolid B up-regulates the expression of DME MVD |
[24] |
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone inhibits the expression of DME MVD |
[25] |
| Other Chemical Compound(s) or Element(s) |
| Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Cupric oxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00840
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Chemical Compound |
| DME Modulation |
Cupric oxide up-regulates the expression of DME MVD |
[26] |
|
|
|
|
|
|